Skip to main navigation Skip to search Skip to main content

Biological activity of papain and papain-like (Cathepsin-K and cathepsin-B) enzymes as therapeutical modality candidates in degrading collagen in abnormal scar

  • Herman Y.L. Wihastyoko*
  • , Setyawati Soeharto
  • , Edi Widjajanto
  • , Kusworini
  • , Bambang Pardjianto
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: This study aims to identify the potential of papain as a candidate for the treatment modality for abnormal scars via in silico studies. Methods: We determined the potential mechanism of the process of collagen degradation by papain by investigating its cleavage site-specificity and identifying human papain-like enzymes that have comparable biological activity in degrading collagen in the extracellular matrix using Merops, Bioedit, String DB and Cytoscape software. Results: Papain targets QQ_D (Glutamine-Glutamine Aspartic acid) motif for degradation while collagen only has QQ (Glutamine-Glutamine) motif. Additionally, the homology result showed that Cathepsin B has a closer relationship with papain compared with another candidate, Cathepsin K. Conclusion: Papain is a potential therapeutical modality candidate in degrading collagen in abnormal scars with an indirect mechanism as indicated by its cleavage site-specificity and its relationship with Cathepsin B, which degrades collagen via ubiquitin (UBC) proteasome.

Original languageEnglish
Pages (from-to)4957-4962
Number of pages6
JournalResearch Journal of Pharmacy and Technology
Volume14
Issue number9
DOIs
Publication statusPublished - Sept 2021

Keywords

  • Abnormal scar
  • Cathepsin
  • In silico
  • Papain enzyme

Fingerprint

Dive into the research topics of 'Biological activity of papain and papain-like (Cathepsin-K and cathepsin-B) enzymes as therapeutical modality candidates in degrading collagen in abnormal scar'. Together they form a unique fingerprint.

Cite this